Data

COCOMO-ACS Study: The Colchicine for coronary plaque modification in Acute Coronary Syndrome Study

Health Data Australia Contributor Records
Psaltis, Peter J ; South Australian Health and Medical Research Institute
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.58138/1Q2E-TD39&rft.title=COCOMO-ACS Study: The Colchicine for coronary plaque modification in Acute Coronary Syndrome Study&rft.identifier=http://doi.org/10.58138/1Q2E-TD39&rft.publisher=South Australian Health and Medical Research Institute&rft.description=This dataset includes 64 participants (median age 61.5 years; 9.4% female) with acute non-ST-segment elevation MI receiving colchicine 0.5 mg daily or placebo; in addition to guideline-recommended therapy. Participants underwent serial Optical Coherence Tomography (OCT) imaging within a matched segment of non-culprit coronary artery that contained at least one lipid-rich plaque causing ≥20% stenosis. At follow up (median of 17.8 months), the primary outcome was the change in minimum fibrous cap thickness (FCT) in non-culprit segments from baseline to final visit. The file is .PDF.HeSANDA 1.0.0&rft.creator=Psaltis, Peter J &rft.creator=South Australian Health and Medical Research Institute &rft.date=2025&rft.relation=https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12618000809235&rft.coverage=South Australia, Victoria, Queensland, New South Wales and Western Australia&rft_subject=FOS: Medical and health sciences&rft_subject=FOS: Clinical medicine&rft.type=dataset&rft.language=English Access the data
Cite Saved to MyRDA Save to MyRDA

Full description

This dataset includes 64 participants (median age 61.5 years; 9.4% female) with acute non-ST-segment elevation MI receiving colchicine 0.5 mg daily or placebo; in addition to guideline-recommended therapy. Participants underwent serial Optical Coherence Tomography (OCT) imaging within a matched segment of non-culprit coronary artery that contained at least one lipid-rich plaque causing ≥20% stenosis. At follow up (median of 17.8 months), the primary outcome was the change in minimum fibrous cap thickness (FCT) in non-culprit segments from baseline to final visit. The file is .PDF.
HeSANDA 1.0.0

Collected:

Data time period: 2018 2022

This dataset is part of a larger collection

Click to explore relationships graph
Help

Related Publications

Related Organisations

Spatial Coverage And Location

text: South Australia, Victoria, Queensland, New South Wales and Western Australia

Subjects
FOS: Clinical medicine | FOS: Medical and health sciences |

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Other Information
South Australian Health and Medical Research Institute

ROR : https://ror.org/03e3kts06

Identifiers